ストックスクリーナーアプリを入手
216.78
1.13%
2.43
Biogen Inc (BIIB) 最新ニュース
Biogen Expands Autoimmune Pipeline With New Graves’ Disease Trial - TipRanks
Biogen Inc. (NASDAQ:BIIB) Healthcare Momentum Draws Fresh Market Attention - Kalkine Media
What Biogen (BIIB)'s Higher Earnings Guidance and Late-Stage Pipeline Progress Means For Shareholders - Yahoo Finance
OVERSEA CHINESE BANKING Corp Ltd Purchases Shares of 18,867 Biogen Inc. $BIIB - MarketBeat
Wealthfront Advisers LLC Acquires Shares of 16,529 Biogen Inc. $BIIB - MarketBeat
OVERSEA CHINESE BANKING Corp Ltd Acquires Shares of 13,000 Biogen Inc. $BIIB - MarketBeat
66,365 Shares in Biogen Inc. $BIIB Bought by Danske Bank A S - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Biogen Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Biogen (BIIB) And The Alzheimer’s Narrative As Valuation Stays In Focus - simplywall.st
Should You Buy, Sell or Hold Biogen Stock After a 9% Rise in a Month? - TradingView
Impax Global Women's Leadership Fund's Biogen Inc(BIIB) Holding History - GuruFocus
Is Wall Street Bullish or Bearish on Biogen Stock? - Barchart.com
Meeder Advisory Services Inc. Acquires Shares of 4,608 Biogen Inc. $BIIB - MarketBeat
Edmond DE Rothschild Holding S.A. Makes New Investment in Biogen Inc. $BIIB - MarketBeat
Biogen Inc (BIIB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BIIB Stock Price Prediction 2025-2026 | Biogen Inc Forecast - 24/7 Wall St.
Biogen Inc (BIIB) Stock Up 4.2% but GF Value Says Overvalued -- GF Score: 73/100 - GuruFocus
Biogen Inc. stock outperforms competitors on strong trading day - MarketWatch
Biogen (NASDAQ:BIIB) Sets New 1-Year HighTime to Buy? - MarketBeat
Biogen (BIIB) Stock Surges to 52-Week Peak After BlackRock’s $3.4B Investment - Blockonomi
Biogen stock hits 52-week high at 219.94 USD - Investing.com
Biogen stock holds above $212 as Leqembi momentum grows - ad-hoc-news.de
Mitsubishi UFJ Asset Management Co. Ltd. Takes $77.53 Million Position in Biogen Inc. $BIIB - MarketBeat
Deutsche Bank AG Takes $193.16 Million Position in Biogen Inc. $BIIB - MarketBeat
15,985,736 Shares in Biogen Inc. $BIIB Bought by BlackRock Inc. - MarketBeat
Biogen Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Biogen stock holds near $209 after Q2 beat - AD HOC NEWS
Pallas Capital Advisors LLC Acquires Shares of 12,859 Biogen Inc. $BIIB - MarketBeat
K.J. Harrison & Partners Inc Makes New $2.16 Million Investment in Biogen Inc. $BIIB - MarketBeat
Plato Investment Management Ltd Invests $1.49 Million in Biogen Inc. $BIIB - MarketBeat
Lantheus Wins FDA Approval for Alzheimer's Tau PET Imaging Agent - finance.biggo.com
Biogen (NASDAQ:BIIB) Shows Strong Technical Breakout Setup With Perfect Trend Rating - ChartMill
Biogen stock holds steady as new Alzheimer’s imaging agent reshapes dementia diagnostics - Ad-hoc-news.de
Nippon Life Global Investors Americas Inc. Buys New Stake in Biogen Inc. $BIIB - MarketBeat
Biogen Inc. (BIIB) Investor Outlook: Exploring A Promising 13.23% Potential Upside - DirectorsTalk Interviews
Focus Partners Advisor Solutions LLC Buys New Position in Biogen Inc. $BIIB - MarketBeat
NewEdge Advisors LLC Trims Position in Biogen Inc. $BIIB - MarketBeat
Biogen Inc.: Target Price Consensus and Analysts Recommendations | 0R1B | US09062X1037 - marketscreener.com
Biogen Stock (BIIB) Opinions on Analyst Upgrade and Acquisition - Quiver Quantitative
Biogen (BIIB) Edges Higher to $210.65 as Biotech Sentiment FirmsQuality ETF - vinanet.vn
Wolfe Research Issues Rare Double Upgrade for Biogen and AbbVie, Setting $300 Targets - finance.biggo.com
BIIB Upgraded by Wolfe Research -- Price Target Raised to $300 - GuruFocus
Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation - Yahoo Finance
Wolfe Upgrades Biogen to Outperform From Peer Perform, Price Target is $300 - marketscreener.com
Handelsbanken Fonder AB Has $20.14 Million Stock Holdings in Biogen Inc. $BIIB - MarketBeat
BIIB Q2 2026 Earnings: Strong EPS Surprise of 19.75% Lifts SharesAnnual Report - vinanet.vn
Formation Bio taps Biogen, Pfizer alum to tackle R&D’s ‘boring middle’ - Pharma Voice
Insight Wealth Strategies LLC Has $7.20 Million Holdings in Biogen Inc. $BIIB - MarketBeat
Biogen Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
HSBC Adjusts Price Target on Biogen to $165 From $157, Keeps Reduce Rating - marketscreener.com
Biogen Inc. (BIIB) Stock Analysis: Uncovering A Potential 13% Upside - DirectorsTalk Interviews
Should Biogen’s Profit Squeeze Amid Rising New-Therapy Sales Prompt Action From Biogen (BIIB) Investors? - simplywall.st
Biogen Inc. (BIIB) Options Chain - Yahoo! Finance Canada
Biogen Inc (BIIB) Stock News Today - TradingKey
Biogen (BIIB) Q2 2026 Earnings Call Transcript - The Globe and Mail
Is Biogen (BIIB) Fully Priced After Earnings Raised Revenue But Cut Profit? - simplywall.st
Biogen, Investors Reach Settlement Outline Over Alzheimer’s Drug - Bloomberg Law News
Biogen Completes RayThera Acquisition - Contract Pharma
Biogen closes deal for USD 1b buyout of RayThera - AllSci
Biogen Completes Acquisition of RayThera Inc. - Biogen
Biogen Completes Acquisition of RayThera, Expanding Immunology Portfolio - Quiver Quantitative
Press Release: Biogen Completes Acquisition of RayThera Inc. - moomoo.com
FMR LLC discloses 12.4% Biogen Inc (BIIB) stake totaling 18.29M shares - Stock Titan
Biogen Inc (BIIB) Director Lloyd Minor Sells 1,186 Shares - GuruFocus
Segall Bryant & Hamill LLC Makes New $1.02 Million Investment in Biogen Inc. $BIIB - marketbeat.com
1.01%
大文字化:
|
ボリューム (24 時間):